View Single Post
Old 08-11-2013, 11:20 AM
indigogo's Avatar
indigogo indigogo is offline
Senior Member
 
Join Date: Aug 2006
Location: "all the way over on the West Coast"
Posts: 1,032
15 yr Member
indigogo indigogo is offline
Senior Member
indigogo's Avatar
 
Join Date: Aug 2006
Location: "all the way over on the West Coast"
Posts: 1,032
15 yr Member
Default

Quote:
Originally Posted by pegleg View Post
Until we have some research proven biomarkers or diagnostic tests for PD, it will never be valid assessment measures. Most of the main assessment test of every trial design uses the UPDRS. ( see this information - http://www.alz.washington.edu/NONMEM.../VER1_2/b3.pdf )
It has its problems but it has been used 20+ years.

Most all research testing is based on observed performance, leaving too much chance or rater bias (subjective opinion). Our concerns are real when it comes to accurate diagnosis.
Peggy
Amen Sister!! The whole thing is a big mess. Thank goodness MJFF decided to invest 50 million in their Parkinson's Progressive Markers Initiative (PPMI). The early data is already being shared worldwide. It is open for use among all researchers. Hopefully, we will learn more about subtypes, and develop an accurate test for diagnosis.

How can we cure/fix it if we don't know what it is?
__________________
Carey

“Cautious, careful people, always casting about to preserve their reputation and social standing, never can bring about a reform. Those who are really in earnest must be willing to be anything or nothing in the world’s estimation, and publicly and privately, in season and out, avow their sympathy with despised and persecuted ideas and their advocates, and bear the consequences.” — Susan B. Anthony
indigogo is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
lindylanka (08-11-2013), RLSmi (08-13-2013), violet green (08-12-2013)